S

S is a GLP-1 receptor agonist that has gained significant attention in clinical settings for its potential to support metabolic health. Originally developed for glycemic control, it is now widely studied for its role in appetite regulation and body composition management. S may help promote feelings of fullness, reduce cravings, and support more sustainable dietary habits, making it a valuable tool for providers focused on weight management protocols. Its once-weekly dosing and growing body of research have made it a preferred option among healthcare professionals exploring GLP-based therapies.